We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Genome & Company is a biotech company engaged in microbiome-based new drug development and contract development and manufacturing (CDMO) services. Its core business areas include the development of microbiome immuno-oncology drugs, novel target immuno-oncology drugs, and consumer healthcare products. Specifically, the company is concentrating on the development of microbiome immuno-oncology drug candidates, such as 'GEN-001'.
지놈앤컴퍼니는 마이크로바이옴 기반의 신약 개발 및 위탁개발생산(CDMO) 사업을 영위하는 바이오 기업입니다. 주요 사업 영역은 마이크로바이옴 면역항암제, 신규 타겟 면역항암제 개발 및 컨슈머 헬스케어 제품입니다. 특히 마이크로바이옴 면역항암제 후보물질 'GEN-001' 등의 개발에 집중하고 있습니다.